Erythema dyschromicum perstans

Dermatology Online Journal

Volumn 16, Issue 11, 2010, Pages

  Tlougan, Brook E ^a   Gonzalez, Mercedes E ^a   Mandal, Rajni V ^a   Kundu, Roopal V ^a   Skopicki, Debra L ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASHY DERMATOSIS; CASE REPORT; ERYTHEMA; HISPANIC; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; LICHENOID ERUPTION; MALE; PHOTOTHERAPY; PHYSICAL EXAMINATION; ULTRAVIOLET B RADIATION; ARM; PATHOLOGY;

ADULT; ARM; ERYTHEMA; HUMANS; HYPERPIGMENTATION; MALE; ULTRAVIOLET THERAPY;

EID: 78650541616     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ramirez CO. Los cenicientos: problema clinica. In: Memoria del Primer Congresso Centroamericano de Dermatologica, December 5-8, 1957, San Salvador, El Salvador 1957: 122 [PubMed]
2. Convit J, et al. Erythema dyschromicum perstans: a hitherto undescribed skin disease. J Invest Dermatol 1961; 36: 457 [PubMed]
3. Chang MW. Disorders of Hyperpigmentation. In: Bolognia JL, et al eds. Dermatology, 2nd ed. Mosby, Elsevier Limited, 2008: 939 [PubMed]
4. Schwartz RA. Erythema dyschromicum perstans: the continuing enigma of Cinderella or ashy dermatosis. Int J Dermatol 2004; 43: 230 [PubMed]
5. Srivastava N, et al. Ashy dermatosis-like pigmentation due to ethambutol. Indian J Dermatol Venereol Leprol 2008; 74; 281 [PubMed]
6. Correa MC, et al. HLA-DR association with the genetic susceptibility to develop ashy dermatosis in Mexican Mestizo patients. J Am Acad Dermatol 2007; 56: 617 [PubMed]
7. Zaynoun S, et al. Ashy dermatoses -a critical review of the literature and a proposed simplified clinical classification. Int J Dermatol 2008; 47: 542 [PubMed]
8. Sanz de Galdeano C, et al. Idiopathic eruptive macular pigmentation: a report of five patients. Pediatr Dermatol 1996; 13: 274 [PubMed]
9. Combemale P, et al. Erythema dyschromicum perstans: report of a new case and critical review of the literature. J Dermatol 1998; 25: 747 [PubMed]
10. Silverberg NB, et al. Erythema dyschromicum perstans in prepubertal children. Pediatr Dermatol 2003; 20: 398 [PubMed]
11. Piquero-Martin J, et al. Clinical trial with clofazimine for treating erythema dyschromicum perstans: evaluation of cell-mediated immunity. Int J Dermatol 1989; 28: 198 [PubMed]
12. Baranda L, et al. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis): the effect of clofazimine therapy. Arch Dermatol 1997; 133: 325 [PubMed]
13. Kontochristopoulos G, et al. Erythema dyschromicum perstans: response to dapsone therapy. Int J Dermatol 1998; 37: 796 [PubMed]
14. Osswald SS, et al. Erythema dyschromicum perstans: a case report and review. Cutis 2001; 68: 25 [PubMed]
15. Honigsmann H, Schwarz T. Ultraviolet Therapy. In: Bolognia JL, et al eds. Dermatology, 2nd ed. Mosby, Elsevier Limited, 2008: 2053 [PubMed]
16. Kocaturk E, et al. Narrowband UVB treatment of pigmented purpuric lichenoid dermatitis (Gougerot-Blum). Photodermatol Photoimmunol Photomed 2009; 25: 55 [PubMed]